DekaBank Deutsche Girozentrale’s Aurinia Pharmaceuticals AUPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-7,480
Closed -$60K 1399
2025
Q1
$60K Buy
+7,480
New +$60.6K ﹤0.01% 1276
2024
Q2
Sell
-7,480
Closed -$36K 1456
2024
Q1
$36K Sell
7,480
-11,608
-61% -$78.7K ﹤0.01% 1394
2023
Q4
$172K Buy
19,088
+10,640
+126% +$87.6K ﹤0.01% 1237
2023
Q3
$65K Buy
+8,448
New +$82.6K ﹤0.01% 1363
2022
Q4
Sell
-50,200
Closed -$362K 1343
2022
Q3
$362K Hold
50,200
﹤0.01% 1104
2022
Q2
$501K Hold
50,200
﹤0.01% 1019
2022
Q1
$622K Buy
50,200
+4,600
+10% +$71.1K ﹤0.01% 1018
2021
Q4
$1.02M Hold
45,600
﹤0.01% 933
2021
Q3
$1.04M Hold
45,600
﹤0.01% 892
2021
Q2
$586K Hold
45,600
﹤0.01% 1038
2021
Q1
$565K Hold
45,600
﹤0.01% 1007
2020
Q4
$623K Buy
45,600
+8,700
+24% +$127K ﹤0.01% 978
2020
Q3
$518K Buy
+36,900
New +$535K ﹤0.01% 924

Other funds holding AUPH

DekaBank Deutsche Girozentrale's AUPH Position: Q2 2025 in Review

DekaBank Deutsche Girozentrale sold out of Aurinia Pharmaceuticals (AUPH) in Q2 2025, closing a stake of 7,480 shares — an estimated $60K sold.

DekaBank Deutsche Girozentrale first reported a position in AUPH in Q3 2020 and held it in 13 quarters. The position peaked at $1.04M in Q3 2021. 219 funds tracked by Wall St. Rank hold AUPH as of Q2 2025.

  • DekaBank Deutsche Girozentrale reported no remaining Aurinia Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • DekaBank Deutsche Girozentrale sold 7,480 Aurinia Pharmaceuticals shares in Q2 2025, an estimated $60K.
  • DekaBank Deutsche Girozentrale first reported a position in Aurinia Pharmaceuticals in Q3 2020 and held it in 13 quarters.
  • DekaBank Deutsche Girozentrale's Aurinia Pharmaceuticals position peaked at $1.04M in Q3 2021.
  • 219 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2025.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2025, filed 30 Jul 2025.